• A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection
• A comprehensive review of <em>Wolbachia</em>-mediated mechanisms to control dengue virus transmission in <em>Aedes aegypti</em> through innate immune pathways
• A prM mutation that attenuates dengue virus replication in human cells enhances midgut infection in mosquitoes
• A simple nomogram to predict dengue shock syndrome: A study of 4522 south east Asian children
• A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus
• A Virtual Assessment Model for At-Home Evaluation of Suspected Viral Hemorrhagic Fever Cases
• AI-driven convolutional neural networks for accurate identification of yellow fever vectors
• Altered neutrophil responses to dengue virus serotype three: delayed apoptosis is regulated by stabilisation of Mcl-1
• Amugulang virus, a novel hantavirus harboured by small rodents in Hulunbuir, China
• An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines
• An Observational Study to Find the Association of Viral Load, NS1 Antigen, IgG Antibody, and Other Laboratory Parameters With the Outcome of Dengue Patients in Eastern India
• Analysis of Prevention, Detection, and Response Measures of Major Infectious Diseases by Modern Chinese Seaport Quarantine Institutions: A Case Study of Modern Tianjin Seaport Quarantine
• Can global health security frameworks measure One Health implementation in West Africa?A mixed-methods study
• Case report: liver failure as a debut of autoimmune hepatitis triggered by dengue virus in a pregnant woman
• Characterization of mosquito host-biting networks of potential Rift Valley fever virus vectors in north-eastern KwaZulu-Natal province, South Africa
• Clinical Profile of Dengue Seropositive Infection From a Tertiary Care Hospital Situated in Mysuru, South India
• Common arboviruses and the kidney: a review
• Comparison of Aedes aegypti arbovirus transmission thresholds in two communities with differing water supply infrastructure
• Comparison of epidemiological characteristics between hemorrhagic fever with renal syndrome patients and severe fever with thrombocytopenia syndrome patients
• Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease
• Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine
• Complete Blood Count Values Over Time in Young Children During the Dengue Virus Epidemic in the Dominican Republic From 2018 to 2020
• Comprehensive Characterization of the Genetic Landscape of African Swine Fever Virus: Insights into Infection Dynamics, Immunomodulation, Virulence and Genes with Unknown Function
• Considerations for the acute management of stroke during the dengue epidemic
• Contemplating dengue: the thinker's reflection on symptoms
• Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice
• Cross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses
• Cross-Reactive Antibodies to the NS1 Protein of Omsk Hemorrhagic Fever Virus Are Absent in the Sera of Patients with Tick-Borne Encephalitis
• Cytokine Storm Syndrome Associated with Hemorrhagic Fever and Other Viruses
• Deciphering the enigma of Lassa virus transmission dynamics and strategies for effective epidemic control through awareness campaigns and rodenticides
• Dengue and leptospirosis coinfection: a case series
• Dengue encephalitis in Argentina
• Dengue in Argentina and current strategies for its control
• Dengue: the threat to health now and in the future
• Designing a Conserved Immunogenic Peptide Construct from the Nucleocapsid Protein of <em>Puumala orthohantavirus</em>
• Double stigma: a cross-sectional study of Lassa patients with hearing loss in North Central Nigeria
• Effectiveness and safety of the tetravalent TAK-003 dengue vaccine: a systematic review
• Effectiveness of mass trapping interventions using autocidal gravid ovitraps (AGO) for the control of the dengue vector, Aedes (Stegomyia) aegypti, in Northern Mexico
• Elevated NS1 serum levels reduce CD119 expression and CXCL-10 synthesis in patients with dengue hemorrhagic fever
• Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein
• Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
• Estimation of population age structure, daily survival rates, and potential to support dengue virus transmission for Florida Keys Aedes aegypti via transcriptional profiling
• Evaluating quasi-experimental approaches for estimating epidemiological efficacy of non-randomised field trials: applications in Wolbachia interventions for dengue
• Evaluation of in-house dengue real-time PCR assays in West Java, Indonesia
• Evaluation of the relationship between YKL-40 level and clinical severity in patients with Crimean-Congo hemorrhagic fever
• Evaluation of the Viral Hemorrhagic Fever Surveillance System in the Assaba region, Mauritania (2020-2022)
• Field deployment of <em>Wolbachia</em>-infected <em>Aedes aegypti</em> using uncrewed aerial vehicle
• First detection of Rift Valley Fever Virus among Culex pipiens in Tahoua, Niger
• First Isolation and Molecular Characterization of Umatilla Virus (Sedoreoviridae, Orbivirus) in Brazil
• Fully human monoclonal antibodies against Ebola virus possess complete protection in a hamster model
• Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
• Genome-wide characterization of structure variations in the Xiang pig for genetic resistance to African swine fever
• Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection
• Genomic characterization of Volzhskoe tick virus (Bunyaviricetes) from a Hyalomma marginatum tick, Hungary
• Genomic Epidemiology of Rift Valley Fever Virus Involved in the 2018 and 2022 Outbreaks in Livestock in Rwanda
• High seroreactivities to orthoebolaviruses in rural Cameroon: a case-control study on non-human primate bites and a cross-sectional survey in rural population
• High-Level Isolation: A Landscape Analysis of Global Capabilities and Opportunities to Advance the Field
• Hippo signaling pathway regulates Ebola virus transcription and egress
• Identification, Characterization, and Homology Analysis of a Novel Strain of the Crimean-Congo Hemorrhagic Fever Virus from Yunnan, China
• Immuno-Haematologic Aspects of Dengue Infection: Biologic Insights and Clinical Implications
• Implementation of a High-Level Isolation Unit Readiness Checklist in the Irish Setting
• Increased number of dengue fever cases in the United States of America and its territories in 2024
• Kinetics of dengue viremia and its association with disease severity: an ambispective study
• Knowledge and Attitudes Regarding Crimean-Congo Hemorrhagic Fever Among Slaughterhouse Workers in Sana'a and Dhamar Cities-Yemen: A Cross-Sectional Study
• Knowledge, attitudes, and practices of healthcare professionals regarding dengue fever in high-risk regions of southeastern Iran
• Macrophage Activation Syndrome in Viral Sepsis
• Methodology for the Differential Classification of Dengue and Chikungunya According to the PAHO 2022 Diagnostic Guide
• Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus
• Mpox outbreaks in Africa-we must avert another failure of global solidarity
• Multi-epitope peptide vaccines targeting dengue virus serotype 2 created via immunoinformatic analysis
• New biomarkers for liver involvement by dengue infection in adult Vietnamese patients: a case-control study
• North-south pathways, emerging variants, and high climate suitability characterize the recent spread of dengue virus serotypes 2 and 3 in the Dominican Republic
• Notes from the Field: Prevalence of Previous Dengue Virus Infection Among Children and Adolescents Aged 7-16 Years - American Samoa, September-October 2023
• Observations on the dengue vaccination strategy in Argentina
• Perspectives and challenges in developing and implementing integrated dengue surveillance tools and technology in Thailand: a qualitative study
• Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis
• Presentation and outcomes of Lassa fever in children in Nigeria: a prospective cohort study (LASCOPE)
• Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocol
• Probable vector of Crimean-Congo hemorrhagic fever virus; Hyalomma aegyptium: a systematic review and meta-analysis
• Re-Emergence of Rift Valley Fever Virus Lineage H in Senegal in 2022: In Vitro Characterization and Impact on Its Global Emergence in West Africa
• Seroprevalences and their associated predictors of chikungunya, dengue, Japanese encephalitis and zika among forest fringe dwellers of Peninsular Malaysia
• Simulation as Proof of Concept to Assess the Feasibility and Address Uncertainties Regarding Cardiopulmonary Resuscitation in an Adolescent Patient With Viral Hemorrhagic Fever
• Socioeconomic and environmental factors associated with dengue fever incidence in Guatemala: Rising temperatures increase dengue risk
• Spatial mapping of dengue fever prevalence and its association with geo-climatic factors in Lahore, Pakistan
• The 2016 Severe Floods and Incidence of Hemorrhagic Fever With Renal Syndrome in the Yangtze River Basin
• The hnRNP A2B1 is important for the replication of SFTSV and other RNA viruses
• The N and C-terminal deleted variant of the dengue virus NS1 protein is a potential candidate for dengue vaccine development
• The need for active and integrated involvement of the community and health professionals in the prevention and control of dengue hemorrhagic fever in Indonesia
• The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB
• The six-year prevalence of Crimean-Congo Hemorrhagic Fever (CCHF) in Erzurum, Turkey
• Transport of Patients With High-Consequence Infectious Diseases: Development of European Capacity in Norway
• Understanding the delay in identifying Sudan Virus Disease: gaps in integrated disease surveillance and response and community-based surveillance to detect viral hemorrhagic fever outbreaks in Uganda, September 2022
• Unraveling Dengue Virus Diversity in Asia: An Epidemiological Study through Genetic Sequences and Phylogenetic Analysis
• Unravelling tRNA fragments in DENV pathogenesis: Insights from RNA sequencing
• Using Video-Reflexive Methods to Develop a Provider Down Protocol for the New South Wales Biocontainment Center
• Utilization of novel molecular multiplex methods for the detection and, epidemiological surveillance of dengue virus serotypes and chikungunya virus in Burkina Faso, West Africa
• Vaccine approaches and treatment aspects against Crimean Congo hemorrhagic fever
• Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model
• Virus-blocking mosquitoes take flight in the fight against dengue
• Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022